James Talks

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

Sobha Sivaprasad, A Toby Prevost, Joana C. Vasconcelos et al. · The Lancet · 2017 · 372 citations · Full text

Diabetic Retinopathy, Ocular Disease, Retina +7

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Andrew Lotery, Sobha Sivaprasad, Abby O’Connell et al. · The Lancet · 2020 · 218 citations · Full text

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang et al. · Ophthalmology · 2024 · 124 citations · Full text

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 105 citations · Full text

Faricimab Treat-and-extend, Diabetic Retinopathy, Ocular Disease +3

First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration

James Talks, Andrew Lotery, Faruque Ghanchi et al. · Ophthalmology · 2015 · 99 citations

Ocular Disease, Ophthalmology, Medicine +6